Date published: 2025-10-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ketanserin (CAS 74050-98-9)

0.0(0)
Write a reviewAsk a question

Alternate Names:
3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione
Application:
Ketanserin is a selective serotonin antagonist
CAS Number:
74050-98-9
Purity:
≥99%
Molecular Weight:
395.43
Molecular Formula:
C22H22FN3O3
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Ketanserin is reported to have a high affinity for multiple G protein-coupled receptors, such as serotonin receptors. Ketanserin is a selective serotonin 5-HT2/5-HT1C antagonist. It has been used to distinguish between 5-HT1D and 5-HT1B receptor subtypes. Additional studies have noted that Ketanserin is able to differentiate between recombinant human forms of these receptors with a higher affinity for 5-HT1Dα receptors compared to 5-HT1Dβ receptors.


Ketanserin (CAS 74050-98-9) References

  1. Transport and inhibition mechanisms of human VMAT2.  |  Wu, D., et al. 2024. Nature. 626: 427-434. PMID: 38081299
  2. Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue.  |  Robinson, GI., et al. 2023. Life (Basel). 13: PMID: 38137946
  3. Designer Receptor Exclusively Activated by Designer Drug (DREADD)-Mediated Activation of the Periaqueductal Gray Restores Nociceptive Descending Inhibition After Traumatic Brain Injury in Rats.  |  Irvine, KA., et al. 2024. J Neurotrauma.. PMID: 38588130
  4. Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain.  |  Muneta-Arrate, I., et al. 2024. Br J Pharmacol.. PMID: 38644550
  5. Examination of the effects of vitexin and vitexin-loaded solid lipid nanoparticles on neuropathic pain and possible mechanisms of action.  |  Eken, H., et al. 2024. Neuropharmacology. 253: 109961. PMID: 38657947
  6. Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor.  |  Harari, R., et al. 2024. iScience. 27: 109686. PMID: 38660396
  7. Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats.  |  Jeanblanc, J., et al. 2024. Brain.. PMID: 38703387
  8. Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation.  |  Arias, HR., et al. 2024. Biomed Pharmacother. 177: 116867. PMID: 38889634
  9. Collaborative action between noradrenergic and serotoninergic systems in peripheral antinociception in mice.  |  Aguiar, DD., et al. 2024. J Biosci. 49: PMID: 38920106
  10. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.  |  Van Nueten, JM., et al. 1981. J Pharmacol Exp Ther. 218: 217-30. PMID: 6113280
  11. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.  |  Leysen, JE., et al. 1982. Mol Pharmacol. 21: 301-14. PMID: 7099138
  12. Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein.  |  Razzaque, Z., et al. 1995. Eur J Pharmacol. 283: 199-206. PMID: 7498311
  13. Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes.  |  Zgombick, JM., et al. 1995. Eur J Pharmacol. 291: 9-15. PMID: 8549648

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Ketanserin, 1 g

sc-279249
1 g
$700.00